EBIXA 5 mg/pression, oral solution bottle, 50 ml
Brand page: Ebixa (memantine) — all forms and strengths in France
Active ingredients: Memantine hydrochloride, Memantine
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 50 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EBIXA 5 mg/pression, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 50 ml avec pompe(s) doseuse(s)
- Marketing authorisation holder
- LUNDBECK (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 11 Aug 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61182432CIP73595560CIP133400935955609Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE MÉMANTINEsolution | 5 mg · une pression | SA |
| MÉMANTINE BASEsolution | 4,16 mg · une pression | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.